1. FDA clears narrow use of Lynparza in early prostate cancer — AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral --FDA approves Pfizer’s RSV vaccine for older adults -- See more on our front page news http://bit.ly/w28kSd See more on our front page news
    Dismiss Notice

OFF LABEL PROCEDURES

Discussion in 'Ask a Whistleblower Attorney' started by Reaper, Nov 17, 2021 at 10:24 AM.

  1. #1 Reaper, Nov 17, 2021 at 10:24 AM
    Reaper

    Reaper new user

    Joined:
    Nov 16, 2021
    Messages:
    3
    Likes Received:
    0
    Top tier medical device company not only participating in but PROMOTING off label use of their medical device. This company encourages this practice... all in the name of sales (obviously). Endovascular community.
     
    Quote

  2. #2 Constantine Cannon, Dec 16, 2021 at 1:32 PM
    Constantine Cannon

    Constantine Cannon Experienced Whistleblower Law Firm

    Joined:
    Aug 20, 2019
    Messages:
    18
    Likes Received:
    0
    Promoting medical devices for off-label uses can form the basis of a False Claims Act violation. You can read more about off-label marketing and the False Claims Act here: Medical Devices and DME Fraud | Learn More - Constantine Cannon

    If you're considering blowing the whistle, we recommend reaching to a whistleblower attorney to help navigate the process. You can read more about that process here: I Think I Have a Whistleblower Lawsuit - Constantine Cannon

    The information contained herein is for informational purposes only and is not legal advice or a substitute for legal counsel. Online readers should not act upon this information without seeking professional counsel. If you would like more information, or would like to speak to a member of Constantine Cannon’s whistleblower lawyer team, please contact us for a Confidential Consultation: https://constantinecannon.com/practice/whistleblower/team/.
     
    Quote
Reply to Thread